Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03747302 · ClinicalTrials.gov registry record · NA
HPV Message Testing and Social Media Campaign
A NA study of Human Papilloma Virus and Vaccine, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 1,043
- Enrollment target
- 1
- Study location
NCT03747302 is a NA study of Human Papilloma Virus and Vaccine that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 1,043 participants, above the 584-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03747302, a NA study of Human Papilloma Virus and Vaccine, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,043 participants
- Enrollment target
- 1
- Study location
Study Summary
This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.
Conditions Studied
Interventions
- OTHER Social Media Message about HPV and HPV vaccine
- OTHER Social media message about risk of electronic cigarettes.
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,043 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2019-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03747302
The ClinicalTrials.gov registry entry for NCT03747302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,043 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 584-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (79% higher). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 2 interventions - of which Social Media Message about HPV and HPV vaccine is the first listed.
NCT03747302 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT03747302 about?
NCT03747302 is a clinical study titled "HPV Message Testing and Social Media Campaign". This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimate...
What is the current status of trial NCT03747302?
This trial is currently completed. It is a NA study. The enrollment target is 1,043 participants. The study started on 2018-12-12. Estimated completion is 2019-09-09.
What conditions does trial NCT03747302 study?
This clinical trial studies the following conditions: Human Papilloma Virus, Vaccine.
What interventions are being tested in trial NCT03747302?
The interventions under investigation include: Social Media Message about HPV and HPV vaccine (OTHER), Social media message about risk of electronic cigarettes. (OTHER).
Who is sponsoring clinical trial NCT03747302?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03747302 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Impact of Financial Incentives
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.